Review



cd25 cell depletion  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Miltenyi Biotec cd25 cell depletion
    Chicken <t>CD25-specific</t> antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.
    Cd25 Cell Depletion, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 44 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd25 cell depletion/product/Miltenyi Biotec
    Average 94 stars, based on 44 article reviews
    cd25 cell depletion - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Depletion of CD25 + cells restores Th1, Th2 and Th17 responses and mitigates Eimeria maxima infection in chickens"

    Article Title: Depletion of CD25 + cells restores Th1, Th2 and Th17 responses and mitigates Eimeria maxima infection in chickens

    Journal: Poultry Science

    doi: 10.1016/j.psj.2026.106467

    Chicken CD25-specific antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.
    Figure Legend Snippet: Chicken CD25-specific antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.

    Techniques Used: Purification, Western Blot, Amplification, Marker

    Dynamic changes in chicken CD4 + CD25 + T cells in PBMCs and splenocytes of E. maxima -infected chickens. The flow cytometry serial gating strategy for detection of the percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs (A) and splenocytes (B). (C) The percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs at 0, 3, 7, 11, 14 and 21 days post-infection. (D) The percentage of CD4 + CD25 + T cells/CD4 + T cells in splenocytes at 0, 3, 7, 11, 14 and 21 days post-infection. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
    Figure Legend Snippet: Dynamic changes in chicken CD4 + CD25 + T cells in PBMCs and splenocytes of E. maxima -infected chickens. The flow cytometry serial gating strategy for detection of the percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs (A) and splenocytes (B). (C) The percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs at 0, 3, 7, 11, 14 and 21 days post-infection. (D) The percentage of CD4 + CD25 + T cells/CD4 + T cells in splenocytes at 0, 3, 7, 11, 14 and 21 days post-infection. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Techniques Used: Infection, Flow Cytometry

    Effect of CD25 + cells depletion in vitro on the immunomodulatory function of PBMCs infected with E. maxima . (A) The percentage of CD25 + cells in chicken PBMCs before depletion in vitro . (B) The percentage of CD25 + cells in chicken PBMCs after depletion in vitro . (C) The effect of E. maxima sporozoite protein stimulation on the cell proliferation in PBMCs depleted with CD25 + cells in vitro . (D-J) The effects of E. maxima sporozoite protein stimulation on the mRNA levels of cytokines and CTLA-4 in PBMCs depleted with CD25 + cells in vitro . * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
    Figure Legend Snippet: Effect of CD25 + cells depletion in vitro on the immunomodulatory function of PBMCs infected with E. maxima . (A) The percentage of CD25 + cells in chicken PBMCs before depletion in vitro . (B) The percentage of CD25 + cells in chicken PBMCs after depletion in vitro . (C) The effect of E. maxima sporozoite protein stimulation on the cell proliferation in PBMCs depleted with CD25 + cells in vitro . (D-J) The effects of E. maxima sporozoite protein stimulation on the mRNA levels of cytokines and CTLA-4 in PBMCs depleted with CD25 + cells in vitro . * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Techniques Used: In Vitro, Infection

    Interference impact of CD25 + cells depletion in vivo on the immunomodulatory function of PBMCs infected with E. maxima . (A) Dynamic changes of the percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs injected intravenously with rat anti-chicken CD25 polyclonal antibody. (B) The effects of E. maxima sporozoite protein stimulation on the cell proliferation in PBMCs blocked with CD25 molecule in vivo . (C-I) The effects of E. maxima sporozoite protein stimulation on the mRNA levels of cytokines and CTLA-4 in PBMCs blocked with CD25 molecule in vivo . * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
    Figure Legend Snippet: Interference impact of CD25 + cells depletion in vivo on the immunomodulatory function of PBMCs infected with E. maxima . (A) Dynamic changes of the percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs injected intravenously with rat anti-chicken CD25 polyclonal antibody. (B) The effects of E. maxima sporozoite protein stimulation on the cell proliferation in PBMCs blocked with CD25 molecule in vivo . (C-I) The effects of E. maxima sporozoite protein stimulation on the mRNA levels of cytokines and CTLA-4 in PBMCs blocked with CD25 molecule in vivo . * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Techniques Used: In Vivo, Infection, Injection



    Similar Products

    94
    Miltenyi Biotec cd25 cell depletion
    Chicken <t>CD25-specific</t> antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.
    Cd25 Cell Depletion, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd25 cell depletion/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    cd25 cell depletion - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec cd4 cd25 regulatory t cell isolation kit
    Chicken <t>CD25-specific</t> antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.
    Cd4 Cd25 Regulatory T Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4 cd25 regulatory t cell isolation kit/product/Miltenyi Biotec
    Average 97 stars, based on 1 article reviews
    cd4 cd25 regulatory t cell isolation kit - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    98
    Miltenyi Biotec mouse
    Chicken <t>CD25-specific</t> antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.
    Mouse, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse/product/Miltenyi Biotec
    Average 98 stars, based on 1 article reviews
    mouse - by Bioz Stars, 2026-02
    98/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec magnetic beads
    Chicken <t>CD25-specific</t> antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.
    Magnetic Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/magnetic beads/product/Miltenyi Biotec
    Average 96 stars, based on 1 article reviews
    magnetic beads - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd4 cd25 cd127dim
    ( A ) Purified human <t>CD4</t> T cells were incubated with rhCD318 (10402-CU-050, R&D System) for 30 min on ice, followed by staining with anti–CD6-BV421 and anti–CD318-APC to measure the binding of rhCD318 on CD4 T cells. Data shown are representative of individual donors from multiple experiments. n = 5, n indicates biological replicates. ( B ) Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed BSM and Priess, and the expression of CD69 and <t>CD25</t> was measured. n = 3 to 6, n indicates technical replicates. ( C ) Je6-NF-κB::eGFP Jurkat cells were CD6 KD by nucleofection. CD6 expression was measured by after 24 hours. ( D ) CD318 KD Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed Priess, and the expression of CD69 and NF-κB::eGFP was measured. n = 3, n indicates technical replicates. Data represent mean ± SEM. Statistical significance was assessed using a one-way ANOVA followed by multiple-comparison analysis. * P < 0.05, *** P < 0.001, and **** P < 0.0001.
    Cd4 Cd25 Cd127dim, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4 cd25 cd127dim/product/Miltenyi Biotec
    Average 96 stars, based on 1 article reviews
    cd4 cd25 cd127dim - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd4 cd25 cd127dim regulatory t cell isolation kit ii
    ( A ) Purified human <t>CD4</t> T cells were incubated with rhCD318 (10402-CU-050, R&D System) for 30 min on ice, followed by staining with anti–CD6-BV421 and anti–CD318-APC to measure the binding of rhCD318 on CD4 T cells. Data shown are representative of individual donors from multiple experiments. n = 5, n indicates biological replicates. ( B ) Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed BSM and Priess, and the expression of CD69 and <t>CD25</t> was measured. n = 3 to 6, n indicates technical replicates. ( C ) Je6-NF-κB::eGFP Jurkat cells were CD6 KD by nucleofection. CD6 expression was measured by after 24 hours. ( D ) CD318 KD Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed Priess, and the expression of CD69 and NF-κB::eGFP was measured. n = 3, n indicates technical replicates. Data represent mean ± SEM. Statistical significance was assessed using a one-way ANOVA followed by multiple-comparison analysis. * P < 0.05, *** P < 0.001, and **** P < 0.0001.
    Cd4 Cd25 Cd127dim Regulatory T Cell Isolation Kit Ii, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4 cd25 cd127dim regulatory t cell isolation kit ii/product/Miltenyi Biotec
    Average 96 stars, based on 1 article reviews
    cd4 cd25 cd127dim regulatory t cell isolation kit ii - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    98
    Miltenyi Biotec cd4 cd25 treg cells
    ( A ) Purified human <t>CD4</t> T cells were incubated with rhCD318 (10402-CU-050, R&D System) for 30 min on ice, followed by staining with anti–CD6-BV421 and anti–CD318-APC to measure the binding of rhCD318 on CD4 T cells. Data shown are representative of individual donors from multiple experiments. n = 5, n indicates biological replicates. ( B ) Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed BSM and Priess, and the expression of CD69 and <t>CD25</t> was measured. n = 3 to 6, n indicates technical replicates. ( C ) Je6-NF-κB::eGFP Jurkat cells were CD6 KD by nucleofection. CD6 expression was measured by after 24 hours. ( D ) CD318 KD Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed Priess, and the expression of CD69 and NF-κB::eGFP was measured. n = 3, n indicates technical replicates. Data represent mean ± SEM. Statistical significance was assessed using a one-way ANOVA followed by multiple-comparison analysis. * P < 0.05, *** P < 0.001, and **** P < 0.0001.
    Cd4 Cd25 Treg Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4 cd25 treg cells/product/Miltenyi Biotec
    Average 98 stars, based on 1 article reviews
    cd4 cd25 treg cells - by Bioz Stars, 2026-02
    98/100 stars
      Buy from Supplier

    Image Search Results


    Chicken CD25-specific antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.

    Journal: Poultry Science

    Article Title: Depletion of CD25 + cells restores Th1, Th2 and Th17 responses and mitigates Eimeria maxima infection in chickens

    doi: 10.1016/j.psj.2026.106467

    Figure Lengend Snippet: Chicken CD25-specific antiserum preparation, purification, and western blot analysis . (A) The amplification of chicken CD25 gene lane M: DNA Marker DL 2000; lane 1: the amplification products of CD25 gene. (B) Purification of chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: purified chicken pET-28a-CD25 protein. (C) Western blot identification of His-tag in chicken pET-28a-CD25 protein lane M: standard molecular marker for protein; lane 1: identification of His-tag in pET-28a-CD25 protein by mouse anti His-tag monoclonal antibody. (D) Western blot identification of chicken CD25 protein from spleen by rat anti-chicken CD25 polyclonal antibody lane M: standard molecular marker for protein; line 1: identification of CD25 protein by rat anti-chicken CD25 polyclonal antibody (∼23.5 kDa); line 2: identification of CD25 protein by negative rat serum.

    Article Snippet: CD25 + cell depletion was achieved by incubating the PBMCs with 20 μL of FITC-conjugated human anti-chicken CD25 antibody for 20 min at 4°C, followed by an additional 20-min incubation at 4°C with 20 μL of anti-FITC MultiSort MicroBeads antibodies (Miltenyi Biotec, Bergisch Gladbach, North Rhine-Westphalia, Germany).

    Techniques: Purification, Western Blot, Amplification, Marker

    Dynamic changes in chicken CD4 + CD25 + T cells in PBMCs and splenocytes of E. maxima -infected chickens. The flow cytometry serial gating strategy for detection of the percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs (A) and splenocytes (B). (C) The percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs at 0, 3, 7, 11, 14 and 21 days post-infection. (D) The percentage of CD4 + CD25 + T cells/CD4 + T cells in splenocytes at 0, 3, 7, 11, 14 and 21 days post-infection. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Journal: Poultry Science

    Article Title: Depletion of CD25 + cells restores Th1, Th2 and Th17 responses and mitigates Eimeria maxima infection in chickens

    doi: 10.1016/j.psj.2026.106467

    Figure Lengend Snippet: Dynamic changes in chicken CD4 + CD25 + T cells in PBMCs and splenocytes of E. maxima -infected chickens. The flow cytometry serial gating strategy for detection of the percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs (A) and splenocytes (B). (C) The percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs at 0, 3, 7, 11, 14 and 21 days post-infection. (D) The percentage of CD4 + CD25 + T cells/CD4 + T cells in splenocytes at 0, 3, 7, 11, 14 and 21 days post-infection. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Article Snippet: CD25 + cell depletion was achieved by incubating the PBMCs with 20 μL of FITC-conjugated human anti-chicken CD25 antibody for 20 min at 4°C, followed by an additional 20-min incubation at 4°C with 20 μL of anti-FITC MultiSort MicroBeads antibodies (Miltenyi Biotec, Bergisch Gladbach, North Rhine-Westphalia, Germany).

    Techniques: Infection, Flow Cytometry

    Effect of CD25 + cells depletion in vitro on the immunomodulatory function of PBMCs infected with E. maxima . (A) The percentage of CD25 + cells in chicken PBMCs before depletion in vitro . (B) The percentage of CD25 + cells in chicken PBMCs after depletion in vitro . (C) The effect of E. maxima sporozoite protein stimulation on the cell proliferation in PBMCs depleted with CD25 + cells in vitro . (D-J) The effects of E. maxima sporozoite protein stimulation on the mRNA levels of cytokines and CTLA-4 in PBMCs depleted with CD25 + cells in vitro . * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Journal: Poultry Science

    Article Title: Depletion of CD25 + cells restores Th1, Th2 and Th17 responses and mitigates Eimeria maxima infection in chickens

    doi: 10.1016/j.psj.2026.106467

    Figure Lengend Snippet: Effect of CD25 + cells depletion in vitro on the immunomodulatory function of PBMCs infected with E. maxima . (A) The percentage of CD25 + cells in chicken PBMCs before depletion in vitro . (B) The percentage of CD25 + cells in chicken PBMCs after depletion in vitro . (C) The effect of E. maxima sporozoite protein stimulation on the cell proliferation in PBMCs depleted with CD25 + cells in vitro . (D-J) The effects of E. maxima sporozoite protein stimulation on the mRNA levels of cytokines and CTLA-4 in PBMCs depleted with CD25 + cells in vitro . * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Article Snippet: CD25 + cell depletion was achieved by incubating the PBMCs with 20 μL of FITC-conjugated human anti-chicken CD25 antibody for 20 min at 4°C, followed by an additional 20-min incubation at 4°C with 20 μL of anti-FITC MultiSort MicroBeads antibodies (Miltenyi Biotec, Bergisch Gladbach, North Rhine-Westphalia, Germany).

    Techniques: In Vitro, Infection

    Interference impact of CD25 + cells depletion in vivo on the immunomodulatory function of PBMCs infected with E. maxima . (A) Dynamic changes of the percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs injected intravenously with rat anti-chicken CD25 polyclonal antibody. (B) The effects of E. maxima sporozoite protein stimulation on the cell proliferation in PBMCs blocked with CD25 molecule in vivo . (C-I) The effects of E. maxima sporozoite protein stimulation on the mRNA levels of cytokines and CTLA-4 in PBMCs blocked with CD25 molecule in vivo . * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Journal: Poultry Science

    Article Title: Depletion of CD25 + cells restores Th1, Th2 and Th17 responses and mitigates Eimeria maxima infection in chickens

    doi: 10.1016/j.psj.2026.106467

    Figure Lengend Snippet: Interference impact of CD25 + cells depletion in vivo on the immunomodulatory function of PBMCs infected with E. maxima . (A) Dynamic changes of the percentage of CD4 + CD25 + T cells/CD4 + T cells in PBMCs injected intravenously with rat anti-chicken CD25 polyclonal antibody. (B) The effects of E. maxima sporozoite protein stimulation on the cell proliferation in PBMCs blocked with CD25 molecule in vivo . (C-I) The effects of E. maxima sporozoite protein stimulation on the mRNA levels of cytokines and CTLA-4 in PBMCs blocked with CD25 molecule in vivo . * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Article Snippet: CD25 + cell depletion was achieved by incubating the PBMCs with 20 μL of FITC-conjugated human anti-chicken CD25 antibody for 20 min at 4°C, followed by an additional 20-min incubation at 4°C with 20 μL of anti-FITC MultiSort MicroBeads antibodies (Miltenyi Biotec, Bergisch Gladbach, North Rhine-Westphalia, Germany).

    Techniques: In Vivo, Infection, Injection

    ( A ) Purified human CD4 T cells were incubated with rhCD318 (10402-CU-050, R&D System) for 30 min on ice, followed by staining with anti–CD6-BV421 and anti–CD318-APC to measure the binding of rhCD318 on CD4 T cells. Data shown are representative of individual donors from multiple experiments. n = 5, n indicates biological replicates. ( B ) Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed BSM and Priess, and the expression of CD69 and CD25 was measured. n = 3 to 6, n indicates technical replicates. ( C ) Je6-NF-κB::eGFP Jurkat cells were CD6 KD by nucleofection. CD6 expression was measured by after 24 hours. ( D ) CD318 KD Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed Priess, and the expression of CD69 and NF-κB::eGFP was measured. n = 3, n indicates technical replicates. Data represent mean ± SEM. Statistical significance was assessed using a one-way ANOVA followed by multiple-comparison analysis. * P < 0.05, *** P < 0.001, and **** P < 0.0001.

    Journal: Science Advances

    Article Title: CD318 expression defines a novel subset of human CD8 + regulatory T cells

    doi: 10.1126/sciadv.adz4203

    Figure Lengend Snippet: ( A ) Purified human CD4 T cells were incubated with rhCD318 (10402-CU-050, R&D System) for 30 min on ice, followed by staining with anti–CD6-BV421 and anti–CD318-APC to measure the binding of rhCD318 on CD4 T cells. Data shown are representative of individual donors from multiple experiments. n = 5, n indicates biological replicates. ( B ) Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed BSM and Priess, and the expression of CD69 and CD25 was measured. n = 3 to 6, n indicates technical replicates. ( C ) Je6-NF-κB::eGFP Jurkat cells were CD6 KD by nucleofection. CD6 expression was measured by after 24 hours. ( D ) CD318 KD Je6-NF-κB::eGFP Jurkat cells were incubated for 24 hours with superantigen pulsed Priess, and the expression of CD69 and NF-κB::eGFP was measured. n = 3, n indicates technical replicates. Data represent mean ± SEM. Statistical significance was assessed using a one-way ANOVA followed by multiple-comparison analysis. * P < 0.05, *** P < 0.001, and **** P < 0.0001.

    Article Snippet: For suppression assay, we isolated CD4 + CD25 + CD127dim/ − T regs by magnetic beads (130-094-775, Miltenyi Biotech).

    Techniques: Purification, Incubation, Staining, Binding Assay, Expressing, Comparison

    ( A ) Human CD4 and CD8 T cells were tested for the expression of early T cell activation markers after 24 hours of stimulation with anti-CD3 (0.1 μg/ml), without (white dots) or with (black dots) rhCD318 (5 μg/ml, 4°C O/N coat). n = 3. ( B ) Purified CD4 and CD8 T cells were stimulated with plate-bound anti-CD3 (0.5 μg/ml), without (white dots) or with (black dots) rhCD318 (5 μg/ml, 4°C O/N coat). Seven days poststimulation, T cells were restimulated with PMA and ionomycin to measure cytokine expression. The expansion fold was normalized by control anti-CD3 alone (dotted line). Data shown are representative of individual donors from multiple experiments. n = 6 to 10. ( C ) CD127 − CD25 + FOXP3 + T reg proliferation analysis. Microbead-sorted CFSE-labeled T regs were stimulated with CD3 (0.5 μg/ml), without (white dots) or with (black dots) rhCD318 (5 μg/ml, plate coated) at 1 × 10 6 cells/ml with IL-2 (10 IU/ml) for 7 days. T reg expansion is shown on the y axis as the fold change relative to anti-CD3 alone (dotted line). n = 4, n indicates biological replicates. CFSE profiling and cytokine expression were evaluated by flow cytometry. n indicates biological replicates. Data are presented as the mean ± SEM. Statistical significance was assessed using a two-tailed Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. n = 6 to 10.

    Journal: Science Advances

    Article Title: CD318 expression defines a novel subset of human CD8 + regulatory T cells

    doi: 10.1126/sciadv.adz4203

    Figure Lengend Snippet: ( A ) Human CD4 and CD8 T cells were tested for the expression of early T cell activation markers after 24 hours of stimulation with anti-CD3 (0.1 μg/ml), without (white dots) or with (black dots) rhCD318 (5 μg/ml, 4°C O/N coat). n = 3. ( B ) Purified CD4 and CD8 T cells were stimulated with plate-bound anti-CD3 (0.5 μg/ml), without (white dots) or with (black dots) rhCD318 (5 μg/ml, 4°C O/N coat). Seven days poststimulation, T cells were restimulated with PMA and ionomycin to measure cytokine expression. The expansion fold was normalized by control anti-CD3 alone (dotted line). Data shown are representative of individual donors from multiple experiments. n = 6 to 10. ( C ) CD127 − CD25 + FOXP3 + T reg proliferation analysis. Microbead-sorted CFSE-labeled T regs were stimulated with CD3 (0.5 μg/ml), without (white dots) or with (black dots) rhCD318 (5 μg/ml, plate coated) at 1 × 10 6 cells/ml with IL-2 (10 IU/ml) for 7 days. T reg expansion is shown on the y axis as the fold change relative to anti-CD3 alone (dotted line). n = 4, n indicates biological replicates. CFSE profiling and cytokine expression were evaluated by flow cytometry. n indicates biological replicates. Data are presented as the mean ± SEM. Statistical significance was assessed using a two-tailed Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. n = 6 to 10.

    Article Snippet: For suppression assay, we isolated CD4 + CD25 + CD127dim/ − T regs by magnetic beads (130-094-775, Miltenyi Biotech).

    Techniques: Expressing, Activation Assay, Purification, Control, Labeling, Flow Cytometry, Two Tailed Test

    ( A ) ND PBMCs were stimulated with anti-CD3 (1 μg/ml) for 7 days ± rhIL-2 (50 IU/ml). Levels of CD318 were measured from total live cells. n = 4. ( B ) Expression of CD318 on CD4 (white dots) and CD8 (black dots) at days 7, 14, and 21 after stimulation and expansion in vitro. n = 7 to 10. Activated PBMCs were split at day 7 and expanded. For expansion, half of the media was replaced with fresh media containing rhIL-2 (final concentration, 50 IU/ml). ( C ) Cytokine expression in CD318 − (white dots) and CD318 + (black dots) CD8 T cells was measured at day 7 after stimulation. Flow cytometry data shown are representative of three individual donors. n = 3. ( D ) Cytokine secretion was measured from CD318 − (white dots) and CD318 + (black dots) CD8 T cells expanded for 21 days. Supernatants were collected from CD318 − and CD318 + CD8 T cells isolated from 21-day culture-expanded PBMCs and then restimulated with anti-CD3 (1 μg/ml) for 24 hours. n = 3. Cytokine levels were measured by ELISA. ( E ) IFN-γ and TNFα expression on CD318 + CD8 T cells. CD8 T cells expanded for 21 days were enriched with CD318 + CD8 T cells. CD318 + CD8 T cells were restimulated with anti-CD3 (1 μg/ml) alone, or with anti-CD28 (2 μg/ml), anti-CD318 (5 μg/ml), or both anti-CD28 and anti-CD318 together for 24 hours. Cytokine expression was determined by flow cytometry. n = 7, n indicates biological replicates. Data are presented as the mean ± SEM. Statistical significance was assessed using a two-tailed Student’s t test (A) or two-way to [(B) to (D)] or one-way ANOVA followed by multiple-comparison analysis (E). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Journal: Science Advances

    Article Title: CD318 expression defines a novel subset of human CD8 + regulatory T cells

    doi: 10.1126/sciadv.adz4203

    Figure Lengend Snippet: ( A ) ND PBMCs were stimulated with anti-CD3 (1 μg/ml) for 7 days ± rhIL-2 (50 IU/ml). Levels of CD318 were measured from total live cells. n = 4. ( B ) Expression of CD318 on CD4 (white dots) and CD8 (black dots) at days 7, 14, and 21 after stimulation and expansion in vitro. n = 7 to 10. Activated PBMCs were split at day 7 and expanded. For expansion, half of the media was replaced with fresh media containing rhIL-2 (final concentration, 50 IU/ml). ( C ) Cytokine expression in CD318 − (white dots) and CD318 + (black dots) CD8 T cells was measured at day 7 after stimulation. Flow cytometry data shown are representative of three individual donors. n = 3. ( D ) Cytokine secretion was measured from CD318 − (white dots) and CD318 + (black dots) CD8 T cells expanded for 21 days. Supernatants were collected from CD318 − and CD318 + CD8 T cells isolated from 21-day culture-expanded PBMCs and then restimulated with anti-CD3 (1 μg/ml) for 24 hours. n = 3. Cytokine levels were measured by ELISA. ( E ) IFN-γ and TNFα expression on CD318 + CD8 T cells. CD8 T cells expanded for 21 days were enriched with CD318 + CD8 T cells. CD318 + CD8 T cells were restimulated with anti-CD3 (1 μg/ml) alone, or with anti-CD28 (2 μg/ml), anti-CD318 (5 μg/ml), or both anti-CD28 and anti-CD318 together for 24 hours. Cytokine expression was determined by flow cytometry. n = 7, n indicates biological replicates. Data are presented as the mean ± SEM. Statistical significance was assessed using a two-tailed Student’s t test (A) or two-way to [(B) to (D)] or one-way ANOVA followed by multiple-comparison analysis (E). * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

    Article Snippet: For suppression assay, we isolated CD4 + CD25 + CD127dim/ − T regs by magnetic beads (130-094-775, Miltenyi Biotech).

    Techniques: Expressing, In Vitro, Concentration Assay, Flow Cytometry, Isolation, Enzyme-linked Immunosorbent Assay, Two Tailed Test, Comparison

    ( A ) Phenotypic comparison between CD318 − (red dots) and CD318 + (blue dots) CD8 T cells at day 7 after stimulation. Data are representative of three individual donors. n = 3. ( B ) FlowSOM and hierarchical clustering to identify unique CD318 + CD8 T cell clusters. ( C ) Suppressive function of CD318 + CD8 T cells. Expanded CD318 + CD8 T cells were isolated at day 21. CFSE-labeled autologous PBMCs were stimulated with T cell activator anti-CD2/3/28–coated microbeads in the presence of varying numbers of CD318 + (white dots) CD8 T cells and purified natural T regs for positive control (black dots). CFSE-labeled autologous CD4 and CD8 T cell proliferation was evaluated by flow cytometry at day 5. Data shown are representative of multiple experiments. n = 3 to 8, n indicates biological replicates. Data are presented as the mean ± SEM. Statistical significance was assessed using a two-tailed Student’s t test or two-way ANOVA followed by multiple-comparison analysis. *** P < 0.001 and **** P < 0.0001.

    Journal: Science Advances

    Article Title: CD318 expression defines a novel subset of human CD8 + regulatory T cells

    doi: 10.1126/sciadv.adz4203

    Figure Lengend Snippet: ( A ) Phenotypic comparison between CD318 − (red dots) and CD318 + (blue dots) CD8 T cells at day 7 after stimulation. Data are representative of three individual donors. n = 3. ( B ) FlowSOM and hierarchical clustering to identify unique CD318 + CD8 T cell clusters. ( C ) Suppressive function of CD318 + CD8 T cells. Expanded CD318 + CD8 T cells were isolated at day 21. CFSE-labeled autologous PBMCs were stimulated with T cell activator anti-CD2/3/28–coated microbeads in the presence of varying numbers of CD318 + (white dots) CD8 T cells and purified natural T regs for positive control (black dots). CFSE-labeled autologous CD4 and CD8 T cell proliferation was evaluated by flow cytometry at day 5. Data shown are representative of multiple experiments. n = 3 to 8, n indicates biological replicates. Data are presented as the mean ± SEM. Statistical significance was assessed using a two-tailed Student’s t test or two-way ANOVA followed by multiple-comparison analysis. *** P < 0.001 and **** P < 0.0001.

    Article Snippet: For suppression assay, we isolated CD4 + CD25 + CD127dim/ − T regs by magnetic beads (130-094-775, Miltenyi Biotech).

    Techniques: Comparison, Isolation, Labeling, Purification, Positive Control, Flow Cytometry, Two Tailed Test

    ( A ) CD318 costimulation induce phosphorylation of SHP2 in T cell. Human PBMCs were immobilized on plates coated with anti-CD3 and stimulated in the presence or absence of CD318 (5 μg/ml, 4°C O/N coat). n = 4. ( B ) CD318 suppresses T cell proliferation independently of SHP2 inhibition. PBMCs stimulated with plate-bound anti-CD3, in the presence or absence of rhCD318 (5 μg/ml, 4°C O/N coat) and of a SHP2 inhibitor (2 μM) were assessed for T cell proliferation using CFSE profiles at 4 days after stimulation. n = 4. ( C ) Purified CD4 T cells were incubated with plate-bound anti-CD3 ± rhCD318 for 10 min at 37°C. Cells were harvested and immediately analyzed for phosphorylation of ERK1/2, Zap70, and MAPK-p38 by flow cytometry. n = 3, n indicates biological replicates. Data are presented as the mean ± SEM. Statistical significance was assessed using a one-way ANOVA or two-tailed Student’s t test followed by multiple-comparison analysis. * P < 0.05, ** P < 0.01, and **** P < 0.0001.

    Journal: Science Advances

    Article Title: CD318 expression defines a novel subset of human CD8 + regulatory T cells

    doi: 10.1126/sciadv.adz4203

    Figure Lengend Snippet: ( A ) CD318 costimulation induce phosphorylation of SHP2 in T cell. Human PBMCs were immobilized on plates coated with anti-CD3 and stimulated in the presence or absence of CD318 (5 μg/ml, 4°C O/N coat). n = 4. ( B ) CD318 suppresses T cell proliferation independently of SHP2 inhibition. PBMCs stimulated with plate-bound anti-CD3, in the presence or absence of rhCD318 (5 μg/ml, 4°C O/N coat) and of a SHP2 inhibitor (2 μM) were assessed for T cell proliferation using CFSE profiles at 4 days after stimulation. n = 4. ( C ) Purified CD4 T cells were incubated with plate-bound anti-CD3 ± rhCD318 for 10 min at 37°C. Cells were harvested and immediately analyzed for phosphorylation of ERK1/2, Zap70, and MAPK-p38 by flow cytometry. n = 3, n indicates biological replicates. Data are presented as the mean ± SEM. Statistical significance was assessed using a one-way ANOVA or two-tailed Student’s t test followed by multiple-comparison analysis. * P < 0.05, ** P < 0.01, and **** P < 0.0001.

    Article Snippet: For suppression assay, we isolated CD4 + CD25 + CD127dim/ − T regs by magnetic beads (130-094-775, Miltenyi Biotech).

    Techniques: Phospho-proteomics, Inhibition, Purification, Incubation, Flow Cytometry, Two Tailed Test, Comparison

    ( A ) Baseline expression of CD318 in CD4 and CD8 T cells. CD4 and CD8 T cells from ND and T1D PBMCs were measured for CD318 expression by flow cytometry. n = 2 to 9. ( B ) CD318 expression in CD4 and CD8 T cells from ND (white dots) and T1D (black dots) after 7-day stimulation with anti-CD3 + rhIL-2 (50 IU/ml). n = 3 to 10. ( C ) Phosphorylation of mTOR and S6 in CD8 and CD4 T cells. PBMCs from ND and T1D were stimulated with anti-CD3 + rhIL-2 (50 IU/ml) for 16 hours. Phosphorylation was measured in CD8 + and CD4 + T cells by flow cytometry. n = 2 to 4, n indicates biological replicates. Flow cytometry data are representative of multiple experiments. ( D ) Phosphorylation of mTOR and S6 in CD8 T cells at 48 hours. PBMCs from ND and T1D were stimulated with anti-CD3 + rhIL-2 for 48 hours. Phosphorylation was measured in CD8 + T cells by flow cytometry. n = 2 to 4. n indicates biological replicates. Flow cytometry data are representative of two experiments. Data are presented as the mean ± SEM. Statistical significance was assessed using a two-tailed Student’s t test [(B) and (D)] or one-way ANOVA followed by multiple-comparison analysis (C). * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Science Advances

    Article Title: CD318 expression defines a novel subset of human CD8 + regulatory T cells

    doi: 10.1126/sciadv.adz4203

    Figure Lengend Snippet: ( A ) Baseline expression of CD318 in CD4 and CD8 T cells. CD4 and CD8 T cells from ND and T1D PBMCs were measured for CD318 expression by flow cytometry. n = 2 to 9. ( B ) CD318 expression in CD4 and CD8 T cells from ND (white dots) and T1D (black dots) after 7-day stimulation with anti-CD3 + rhIL-2 (50 IU/ml). n = 3 to 10. ( C ) Phosphorylation of mTOR and S6 in CD8 and CD4 T cells. PBMCs from ND and T1D were stimulated with anti-CD3 + rhIL-2 (50 IU/ml) for 16 hours. Phosphorylation was measured in CD8 + and CD4 + T cells by flow cytometry. n = 2 to 4, n indicates biological replicates. Flow cytometry data are representative of multiple experiments. ( D ) Phosphorylation of mTOR and S6 in CD8 T cells at 48 hours. PBMCs from ND and T1D were stimulated with anti-CD3 + rhIL-2 for 48 hours. Phosphorylation was measured in CD8 + T cells by flow cytometry. n = 2 to 4. n indicates biological replicates. Flow cytometry data are representative of two experiments. Data are presented as the mean ± SEM. Statistical significance was assessed using a two-tailed Student’s t test [(B) and (D)] or one-way ANOVA followed by multiple-comparison analysis (C). * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: For suppression assay, we isolated CD4 + CD25 + CD127dim/ − T regs by magnetic beads (130-094-775, Miltenyi Biotech).

    Techniques: Expressing, Flow Cytometry, Phospho-proteomics, Two Tailed Test, Comparison